Showing results (51-60 of 141) with videos related to
Sort By:
Pageof 15
International Immunology|June 30, 2011
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosisYusei Miyazaki, Sachiko Miyake, Asako Chiba, et al.Arthritis and Rheumatism|May 29, 2007
Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritisShinjiro Kaieda, Chiharu Tomi, Shinji Oki, et al.Arthritis and Rheumatism|June 4, 2005
The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine modelsAsako Chiba, Shinjiro Kaieda, Shinji Oki, et al.The Journal of Experimental Medicine|March 6, 2002
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer stainingJenny E Gumperz, Sachiko Miyake, Takashi Yamamura, et al.Biochemical and Biophysical Research Communications|June 7, 2015
ICOS promotes group 2 innate lymphoid cell activation in lungsFumitaka Kamachi, Takuma Isshiki, Norihiro Harada, et al.Nature Communications|July 27, 2025
Convective dynamics in mantle of tidally-locked exoplanetsDaisuke Noto, Takehiro Miyagoshi, Tomomi Terada, et al.Nature Communications|May 21, 2016
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3Atsushi Kadowaki, Sachiko Miyake, Ryoko Saga, et al.Frontiers in Immunology|April 14, 2022
Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA VaccineJie Bai, Asako Chiba, Goh Murayama, et al.Current Topics in Medicinal Chemistry|February 18, 2004
NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune diseaseTakashi Yamamura, Katsuichi Miyamoto, Zsolt Illés, et al.Arthritis Research & Therapy|October 21, 2017
Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosusGoh Murayama, Nanako Furusawa, Asako Chiba, et al.Pageof 15